1. Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104‐week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS). (8th February 2023) Authors: Gargiulo, Luigi; Ibba, Luciano; Malagoli, Piergiorgio; Angileri, Rosa Giuseppa; Bardazzi, Federico; Bernardini, Nicoletta; Burlando, Martina; Carrera, Carlo G.; Chiricozzi, Andrea; Dapavo, Paolo; Dini, Valentina; Fabbrocini, Gabriella; Gaiani, Francesca Maria; Galluzzo, Marco; Giofré, Claudia; Gu... Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 37:Number 5(2023) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗